Loading clinical trials...
Loading clinical trials...
Imaging Stimulant vs. Non-Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
Conditions
Interventions
Guanfacine
Lisdexamfetamine
Locations
1
United States
New York State Psychiatric Institute
New York, New York, United States
Start Date
September 1, 2014
Primary Completion Date
November 6, 2021
Completion Date
November 6, 2021
Last Updated
February 2, 2023
NCT07189442
NCT06123741
NCT06847165
NCT04175041
NCT07459699
NCT07439276
Lead Sponsor
New York State Psychiatric Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions